Therapeutic efficacy of Kalpaamruthaa on reactive oxygen/nitrogen species levels and antioxidative system in mammary carcinoma bearing rats

  • Krishnamurthi Veena
  • Palanivelu Shanthi
  • Panchanatham Sachdanandam


Reactive oxygen species play an important role in cancer and metastasis. Kalpaamruthaa is a modified Siddha preparation, which has been formulated in our laboratory. The preparation is an amalgamation of Semecarpus anacardium (SA), Emblica officinalis (EO) and honey, which gives an extra protectiveness to mammary carcinoma bearing animals (Sprague-Dawley stains were used for this study). The aim of our research is to determine the therapeutic efficiency of the drug with respect to lipid peroxidation and antioxidant status. The levels of lipid peroxides and antioxidant levels were measured in blood, and vital organs (liver, kidney and breast tissue) of control and experimental animals. In cancer condition, the LPO was increased and antioxidant levels were decreased. On drug (SA and KA) administration, decreased LPO and increased antioxidant levels were seen in control and experimental animals. This may be due to additive property of the drugs (SA, Emblica and honey), which possesses anticancer effect. The present study shows the good therapeutic efficacy of Kalpaamruthaa against mammary carcinoma.


Semecarpus anacardium Emblica officinalis lipid peroxidation antioxidant mammary carcinoma 


  1. 1.
    Halliwell B, Aruoma OI (1991) DNA damage by oxygen-derived species: Its mechanism and measurement in mammalian systems. FEBS Lett 281: 9–19PubMedCrossRefGoogle Scholar
  2. 2.
    Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumour cells. Cancer Res 51: 794–798PubMedGoogle Scholar
  3. 3.
    Noguchi N, Watanabe A, Shi H (2000) Diverse functions of antioxidants. Free Radic Res 33: 809–817PubMedCrossRefGoogle Scholar
  4. 4.
    Tiwari AK (2001) Imbalance in antioxidant defence and human disease: Multiple approach of natural antioxidants therapy. Curr Sci 81: 1179–1187Google Scholar
  5. 5.
    Ohshima H, Baithch H (1994) Chronic infections and inflammatory process as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253–264PubMedGoogle Scholar
  6. 6.
    Rajnakova A, Moochhala S, Goh MYP, Ngoi SS (2001) Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stage of human gastric cancer. Cancer Lett 172: 177–185PubMedCrossRefGoogle Scholar
  7. 7.
    Martin JHJ, Alalami O, Van den Berg HW (1999) Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line, which has acquired estrogen independence. Cancer Lett 144: 65–74PubMedCrossRefGoogle Scholar
  8. 8.
    Wollenweber E (1988) Occurrence of flavonoid aglycones in medicinal plants. Prog Clin Biol Res 280: 45–55PubMedGoogle Scholar
  9. 9.
    Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG (1998) Antioxidant efficacy of phytoestrogens in chemical and biological model Systems. Arch Biochem Biophys 360: 142–148PubMedCrossRefGoogle Scholar
  10. 10.
    Van Poppel G, van den Berg H (1997) Vitamins and cancer. Cancer Lett 14: 195–202Google Scholar
  11. 11.
    Veena K, Shanthi P, Sachdanandam P: Anticancer effect of Kalpaamruthaa on mammary carcinoma in rats with reference to glycoprotein components, lysosomal and marker enzymes. Biol Pharm Bull 29: 565–569, 2006Google Scholar
  12. 12.
    Sanz MJ, Ferrandiz ML, Cejudo M, Terencio MC, Gil B, Bustos G, Ubeda A, Gunasekaran R, Alcaraz NJ (1994) Influence of a series of natural flavonoids on free radicals generating systems and oxidative stress. Zenobiotica 24: 689–699CrossRefGoogle Scholar
  13. 13.
    Barnes S (1998) Evolution of the history of soy and genistein. Proc Soc Exp Biol Med 217: 386–392PubMedGoogle Scholar
  14. 14.
    Collins AR (1999) Oxidative DNA damage, antioxidants and cancer. BioEssays 21: 238–246PubMedCrossRefGoogle Scholar
  15. 15.
    Konopacka M, Widel M, Rzeszowska-Wolnyl J (1998) Modifying effects of vitamin C, E and beta-carotene against gamma-ray induced DNA damage in mouse cells. Mutat Res 417: 85–94PubMedGoogle Scholar
  16. 16.
    Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F, Remesy C (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426: 331–336PubMedCrossRefGoogle Scholar
  17. 17.
    Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C (1988) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275: R212–R219Google Scholar
  18. 18.
    Cameron E, Pauling L (1973) Ascorbic acid and the glycosaminoglycans. Oncology 27: 181–192PubMedCrossRefGoogle Scholar
  19. 19.
    Frei B (1994) Reactive oxygen species and antioxidant vitamins: Mechanism of action. Am J Med 97: 5S–13SPubMedCrossRefGoogle Scholar
  20. 20.
    Sujatha V, Muthumanikam V, Rani G, Sachdanandam P (1999) Effect of Semecarpus anacardium Linn. Nut extract on glucose metabolizing enzymes in experimentally induced mammary carcinoma in rats. J Pharm Pharmacol 51: 241Google Scholar
  21. 21.
    Lowry OH, Rosenbrough NJ, Farr AL, Randall AJ: Protein measurement with folin’s phenol reagent. J Biol Chem 193: 265–275, 1951Google Scholar
  22. 22.
    Devasagayam TP, Tarachand U (1987) Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 145: 469–474CrossRefGoogle Scholar
  23. 23.
    Yagi K (1976) Simple fluorimetric assay for lipoperoxide in blood plasma. Biochem Med 15: 212–216PubMedCrossRefGoogle Scholar
  24. 24.
    Marlund S, Marklund G (1974) Involvement of superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47: 469–471CrossRefGoogle Scholar
  25. 25.
    Sinha AK (1979) Colorimetric assay of Catalase. Anal Biochem 47: 380–590Google Scholar
  26. 26.
    Rotruk JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hekstra WG, et al (1973) Selenium, biochemical role as a component of glutathione peroxidase purification and assay. Science 179: 588–590CrossRefGoogle Scholar
  27. 27.
    Moron MS, Difieree JW, Mannerwik KB (1979) Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochem Biophys Acta 582: 67–78PubMedGoogle Scholar
  28. 28.
    Omaye ST, Turabull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62: 1–11Google Scholar
  29. 29.
    Rawal UM, Patel US, Rao GN, Desai RR (1977) Clinical and biochemical studies on cateractous human lens III. Quantitative study of protein, RNA and DNA. Arogya J Health Sci 3: 69–72Google Scholar
  30. 30.
    Wolff SP: Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth Enzymol 23: 180–189, 1994Google Scholar
  31. 31.
    Gutteridge JMC (1981) Thiobarbituric acid-reactivity following iron-dependent freeradical damage to amino acids and carbohydrates. FEBS Lett 128: 343–346PubMedCrossRefGoogle Scholar
  32. 32.
    Nishikimi M, Rao NA, Yagi K (1972) Occurance of superoxide anion in the reaction of reduced phenazine methosulphate and molecular oxygen. Biochem Biophys Res Commun 46: 849–854PubMedCrossRefGoogle Scholar
  33. 33.
    Suhulz K, Kerber S, Kelm M (1999) Re-evaluation of the Griess method for determining NO3/NO2 in aqueous and protein containing samples. Nitric Oxide 3:225–234CrossRefGoogle Scholar
  34. 34.
    Batra S, Ray G, Singh SK, Kumari S, Ravi RNM, Tandon A (1998) Respiratory disease in children are associated with increased serum free radical scavenging activity. Med Sci Res 26: 357–359Google Scholar
  35. 35.
    Liss EA, Videla LA, Gonzatez-Flecha B, Gialivi C, Boveris A (1991) Metabolic regulation in oxidative stress: An overview. In: David JA (Ed) Oxidative Damage and Repair, Chemical, Biological and Medical Aspects. Pergamon Press, Oxford, pp 444–448Google Scholar
  36. 36.
    Thangaraju M, Vijayakalakshmi T, Sachdanandam P (1994) Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer 74: 73–82CrossRefGoogle Scholar
  37. 37.
    Dreher D, Junod AF (1996) Role of oxygen free radicals in cancer development. Eur J Cancer 1: 30–38CrossRefGoogle Scholar
  38. 38.
    Cerutti P (1985) Prooxidant states and tumour promotion. Science 227: 375–381PubMedCrossRefGoogle Scholar
  39. 39.
    Maxwell SRJ (1995) Prospect for the use of antioxidant therapies. Drug 49: 345–361Google Scholar
  40. 40.
    Fenn WO, Gerschman R, Gilbert DL, Terwilliger DE, Cothran FV (1957) Mutagenic effects of high oxygen tension on Escherichia coli. Proc Natl Acad Sci USA 43: 1027–1032PubMedCrossRefGoogle Scholar
  41. 41.
    Flohe L, Beckmann R, Giertz H, Loschen G (1985) Oxygen-centered free radicals a mediators of inflammation. In: Sies H (ed) Oxidative Stress. Academic Press, New York, pp 405–437Google Scholar
  42. 42.
    Halliwell B, Gutteridge JMC (1985) Free Radical in Biology and Medicine. Clarendon, Oxford, EnglandGoogle Scholar
  43. 43.
    Escobar JA, Rubio MA, Lissi EA (1996) SOD and catalase inactivation by siglet oxygen and peroxyl radical. Free Rad Biol Med 20: 285–290PubMedCrossRefGoogle Scholar
  44. 44.
    Weiss SJ, LoBuglio AF (1982) Biology of disease phagocyte generated oxygen metabolites and cellular injury. Lab Invest 47: 5–18PubMedGoogle Scholar
  45. 45.
    Oberley LW, Oberley TD (1986) Free radicals, cancer, and aging. In: Johnson JE Jr, Walford R, Harman D, Miquel J (eds) Free Radicals Aging and Degenerative Diseases, Alan R Liss, New York, pp 325–371Google Scholar
  46. 46.
    Tamir S, Tannenbaus SR (1996) The role of nitric oxide in carcinogenic process. Biochim Biophys Acta 1288: F31–F36PubMedGoogle Scholar
  47. 47.
    Ohshima H, Bartsch H (1994) Chronic infection and inflammatory processes as cancer risk factors: Possible role of NO in carcinogenesis. Mutat Res 305: 253–264PubMedGoogle Scholar
  48. 48.
    Bartosz G (1996) Peroxynitrite: Mediator of the toxic action of nitric oxide. Acta Biochim Polon 43: 645–660PubMedGoogle Scholar
  49. 49.
    Van Acker SABE, Van den Berg D, Tromp MNJL, Griffioen DH, Van Bennekom WP, Van der Vijgh WJF, Bast A (1996) Structural aspects of antioxidant activity of flavonoids. Free Radical Biol Med 20: 331–342CrossRefGoogle Scholar
  50. 50.
    Fraga CG, Martino VS, Ferraro GE, Cousio JD, Boveris A (1987) Flavonoids as antioxidants evaluated by in vitro and in vivo liver chemiluminescence. Biochem Pharmacol 36: 717–720PubMedCrossRefGoogle Scholar
  51. 51.
    Sujatha V, Sachdanandam P (2000) Protective effect of nut milk Semecarpus anacardium Linn. Extract against mammary carcinoma, National Seminar on Frontiers of Research and Development in Medicinal Plant sciences, Lucknow. J Med Aromatic Plant Sci 22: 1–10Google Scholar
  52. 52.
    SugiharaN, Arakawa T, Ohnishi M, Furuno K: Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxides-dependent lipid peroxidation in cultured hepatocytes loaded with alpa-linolenic acid. Free Radic Biol Med 27: 1313–1323, 1999Google Scholar
  53. 53.
    Robak J, Gryglewski RJ (1996) Bioactivity of flavonoids. Pol J Pharmacol 48: 554–564Google Scholar
  54. 54.
    Ignatowicz E, Rybczynska M (1994) Some biochemical and pharmacological aspects of free radical-mediated tissue damage. Pol J Pharmacol 46: 103–114PubMedGoogle Scholar
  55. 55.
    Zieliñska M, Kostrzewa A, Ignatowicz E, Budzianowski J: The flavonoids, quercetin and isorhamnetin 3-O-acylglucosides diminish neutrophil oxidative metabolism and lipid peroxidation. Acta Biochim Pol 48: 183–189, 2001Google Scholar
  56. 56.
    Shutenko Z, Henry Y, Pinard E, et al (1999) Influence of the antioxidant quercertin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem Pharmacol 57: 199–208PubMedCrossRefGoogle Scholar
  57. 57.
    Van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A (1995) Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 214: 755–759PubMedCrossRefGoogle Scholar
  58. 58.
    Barthakur NN, Arnold NP (1991) Chemical analysis of the emblic (Phyllanthus emblica) and its potential as a food source. Sci Hortic 47: 99–105CrossRefGoogle Scholar
  59. 59.
    Majo D, Giammanco M, Guardia ML, Tripoli E, Giammanco S, Finotti E: Flavanones in Citrus fruit: Structure–antioxidant activity relationships. Food Res Int 38: 1161–1166, 2005Google Scholar
  60. 60.
    Akhilender Naidu K (2003) Vitamin C in human health and disease is still a mystery? An overview. Nutr J 2: 1–10CrossRefGoogle Scholar
  61. 61.
    Woo KJ, Jeong Y-J, Inoue H, Park J-W, Kwon TK: Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA binding activity. FEBS Lett 579: 705–711, 2005Google Scholar
  62. 62.
    Owen RW, Giacosa A, Hull WE, Haubner R Spiegelhalder B, Bartsch H (2000) The antioxidant/anticancer potential of phenolic compounds isolated from olive oil. Eur J Cancer 36: 1235–1247PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Krishnamurthi Veena
    • 1
  • Palanivelu Shanthi
    • 2
  • Panchanatham Sachdanandam
    • 1
  1. 1.Department of Medical BiochemistryDR. A. L. Mudaliar Post-Graduate Institute of Basic Medical Sciences, University of MadrasChennaiIndia
  2. 2.Department of PathologyDR. A. L. Mudaliar Post-Graduate Institute of Basic Medical Sciences, University of MadrasChennaiIndia

Personalised recommendations